What impact will this newest fusion modality — PET/MR — have on imaging and the industry? Siemens has a device underway ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
Siemens Medical Solutions has added TruePoint technology to its family of Biograph hybrid PET/CT systems. This addition ...
According to Philips, the GEMINI TF is the first PET system to use atomic particle time-measurements to deliver ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
Siemens recently unveiled TruePoint technology for its Biograph family of hybrid PET/CT systems. Siemens anticipates ...
Hitachi's SceptreC Cardiac PET system designed specifically for cardiac PET, and may serve as an as an alternative ...
Siemens will highlight the Biograph family of PET/CT systems, including the Biograph 64, which provides image quality ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
NumaServer is a tool that is capable of fast, secure transfer of large PET, PET/CT, new SPECT/CT and related image data ...
The standard version of PETLinQ is a Web-based tool for delivering PET images and reports to the referring physician’s ...
The field of molecular imaging continues to grow. GE Healthcare has already invested $160 million in the development of ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...